MyFinsight
Home
About
Contact
Back
Income Statement
UroGen Pharma Ltd. (URGN)
source: myfinsight.com
Download
Download image
Comprehensive loss
-$49,948K
(-49.56%↓ Y/Y)
Net loss
-$49,940K
(-49.51%↓ Y/Y)
Unrealized income (loss) on
investments
-$8K
(-233.33%↓ Y/Y)
Loss before income
taxes
-$48,925K
(-46.64%↓ Y/Y)
Income tax expense
$1,015K
(2571.05%↑ Y/Y)
Interest and other
income, net
$1,299K
(-23.95%↓ Y/Y)
Revenue
$24,215K
(10.83%↑ Y/Y)
Financing on prepaid
forward obligation
$4,644K
(-19.56%↓ Y/Y)
Interest expense on
long-term debt
$4,132K
(19.39%↑ Y/Y)
Operating loss
-$41,448K
(-60.41%↓ Y/Y)
Gross profit
$20,665K
(5.33%↑ Y/Y)
Cost of revenue
$3,550K
(59.26%↑ Y/Y)
Research and development
expenses
$18,914K
(22.80%↑ Y/Y)
Selling, general and
administrative expenses
$43,199K
(43.73%↑ Y/Y)
Back